SOLEY THERAPEUTICS ANNOUNCES $200 MILLION SERIES C FINANCING TO PROPEL LEAD ONCOLOGY PROGRAMS INTO THE CLINIC AND SCALE ITS CELL STRESS SENSING PLATFORM
Further company coverage: [ ]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.